You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
貝康醫療-B(02170.HK)與RheaLabs Pte. Ltd訂立戰略合作協議 攜手打造人工智能賦能的標杆性試管嬰兒(IVF)診所
格隆匯 02-25 22:01

格隆匯2月25日丨貝康醫療-B(02170.HK)公吿,公司全資擁有的BMX Holdco Pte.Ltd.全資子公司Genea Biomedx Pty Ltd.於2025年2月25日與RheaLabs Pte. Ltd訂立了戰略合作協議。該戰略合作協議自簽署日起生效,為期五年,旨在發揮雙方商業優勢的協同效應,共同拓展美國、歐洲、南美和東南亞等地區的輔助生殖行業市場,打造人工智能賦能的標杆性試管嬰兒(IVF)診所。

根據戰略合作協議:(i)Genea Biomedx將向Rhea Labs提供高品質醫療產品及綜合解決方案,支持Rhea Labs生殖機構建設,涵蓋胚胎植入前基因檢測(PGT)實驗室、胚胎實驗室、男科實驗室、冷凍儲存實驗室等整體解決方案,以及適用於多種場景的各類輔助生殖中心設備,包括全時差培養箱(Geri®)和輔助生殖用液(Gems);(ii)Rhea Labs和Genea Biomedx將在美國、歐洲、東南亞等地區共同推動品牌化建設;及(iii)Rhea Labs和Genea Biomedx將基於人工智能技術合作開發新產品。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account